OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of surfactant selection and incorporation on in situ nanoparticle formation from amorphous solid dispersions
Chun‐Wan Yen, Robert J. Kuhn, Chloe Hu, et al.
International Journal of Pharmaceutics (2021) Vol. 607, pp. 120980-120980
Closed Access | Times Cited: 11

Showing 11 citing articles:

Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization
Srushti Tambe, Divya Jain, Saikishore Meruva, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2203-2203
Open Access | Times Cited: 75

Advances in the development of amorphous solid dispersions: The role of polymeric carriers
Jie Zhang, Minshan Guo, Minqian Luo, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 4, pp. 100834-100834
Open Access | Times Cited: 68

Comparative study of binary and ternary axitinib solid dispersions: in vitro physicochemical characterization and in vivo pharmacokinetics
Jianshuo Su, Jie Xu, Shufan Liu, et al.
Journal of Drug Delivery Science and Technology (2025) Vol. 109, pp. 107014-107014
Closed Access

Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution
Miguel O. Jara, Zachary N. Warnken, Sawittree Sahakijpijarn, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2568-2568
Open Access | Times Cited: 13

Encapsulation of astaxanthin in OSA-starch based amorphous solid dispersions with HPMCAS-HF/Soluplus® as effective recrystallization inhibitor
Yinglan Li, Qipeng Wei, Jianshuo Su, et al.
International Journal of Biological Macromolecules (2024), pp. 135421-135421
Closed Access | Times Cited: 2

Fused Deposition Modelling 3D printing and solubility improvement of BCS II and IV active ingredients – A narrative review
Agnès Roche, Noelia M. Sánchez-Ballester, Bernard Bataille, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 507-520
Closed Access | Times Cited: 6

Generality of Enhancing the Dissolution Rates of Free Acid Amorphous Solid Dispersions by the Incorporation of Sodium Hydroxide
H Zhang, Cheng W. Chiang, Tristan Maschmeyer-Tombs, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 7, pp. 3395-3406
Closed Access | Times Cited: 1

Utilizing Molecular Simulations to Examine Nanosuspension Stability
Andrew P. Latham, Elizabeth S. Levy, Benjamin D. Sellers, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 50-50
Open Access | Times Cited: 2

Enhancement of Valsartan Solubility by Amorphous solid Dispersion Ternary System: An Optimization and Characterization
Muhammad Seftian, Marlyn Dian Laksitorini, ‪Teuku Nanda Saifullah Sulaiman‬
Research Journal of Pharmacy and Technology (2024), pp. 3717-3724
Closed Access

Utilizing Molecular Simulation to Examine Nanosuspension Stability
Andrew P. Latham, Elizabeth S. Levy, Benjamin D. Sellers, et al.
(2023)
Open Access

Page 1

Scroll to top